Published in Breast Cancer Res on March 04, 2011
Circulating MiR-125b as a marker predicting chemoresistance in breast cancer. PLoS One (2012) 1.67
Cell-free Circulating miRNA Biomarkers in Cancer. J Cancer (2012) 1.37
Identification and functional screening of microRNAs highly deregulated in colorectal cancer. J Cell Mol Med (2012) 1.34
Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer. Mol Cancer (2013) 1.30
The role of microRNAs in breast cancer migration, invasion and metastasis. Int J Mol Sci (2012) 1.24
MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration. Breast Cancer Res (2014) 1.11
Cancer development, progression, and therapy: an epigenetic overview. Int J Mol Sci (2013) 1.10
Role of deregulated microRNAs in breast cancer progression using FFPE tissue. PLoS One (2013) 1.10
miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9. PLoS One (2013) 1.09
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression. Mol Cancer (2013) 1.09
microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN. Oncol Lett (2012) 1.06
Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer. BMC Genomics (2015) 1.00
MicroRNAs and lung cancers: from pathogenesis to clinical implications. Front Med (2012) 1.00
MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1. J Cell Mol Med (2015) 0.96
MicroRNA 'signature' during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention. Cancer Lett (2013) 0.95
miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets. Mol Cell Endocrinol (2015) 0.94
The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma. Endocr Relat Cancer (2012) 0.91
MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3,6-dihydroxyflavone on 1-methyl-1-nitrosourea-induced breast carcinogenesis. Breast Cancer Res (2012) 0.91
Roles of miR-182 in sensory organ development and cancer. Thorac Cancer (2015) 0.90
Methylation by NSun2 represses the levels and function of microRNA 125b. Mol Cell Biol (2014) 0.90
Comprehensive analysis of microRNAs in breast cancer. BMC Genomics (2012) 0.89
The microRNA-183 cluster: the family that plays together stays together. Nucleic Acids Res (2015) 0.88
Tissue slide-based microRNA characterization of tumors: how detailed could diagnosis become for cancer medicine? Expert Rev Mol Diagn (2014) 0.87
Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence. Oncotarget (2016) 0.86
microRNA Expression in Prospectively Collected Blood as a Potential Biomarker of Breast Cancer Risk in the BCFR. Anticancer Res (2015) 0.86
Plasma exosome microRNAs are indicative of breast cancer. Breast Cancer Res (2016) 0.86
Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer. J Biol Chem (2015) 0.85
The transcriptional co-factor RIP140 regulates mammary gland development by promoting the generation of key mitogenic signals. Development (2013) 0.83
Cancer affects microRNA expression, release, and function in cardiac and skeletal muscle. Cancer Res (2014) 0.83
Polycomb protein family member CBX7 plays a critical role in cancer progression. Am J Cancer Res (2015) 0.83
Ductal carcinoma in situ of the breast: morphological and molecular features implicated in progression. Biosci Rep (2014) 0.81
Suppressing NRIP1 inhibits growth of breast cancer cells in vitro and in vivo. Oncotarget (2015) 0.80
miR-182, of the miR-183 cluster family, is packaged in exosomes and is detected in human exosomes from serum, breast cells and prostate cells. Oncol Lett (2016) 0.80
MicroRNAs discriminate familial from sporadic non-BRCA1/2 breast carcinoma arising in patients ≤35 years. PLoS One (2014) 0.80
MicroRNA-183 Family in Inner Ear: Hair Cell Development and Deafness. J Audiol Otol (2016) 0.79
The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer. Int J Clin Exp Pathol (2015) 0.79
Epigenetic regulation by polycomb group complexes: focus on roles of CBX proteins. J Zhejiang Univ Sci B (2014) 0.78
A Comprehensive Analysis of miRNA/isomiR Expression with Gender Difference. PLoS One (2016) 0.78
Bicistronic gene transfer tools for delivery of miRNAs and protein coding sequences. Int J Mol Sci (2013) 0.78
Expression profiling of selected microRNA signatures in plasma and tissues of Saudi colorectal cancer patients by qPCR. Oncol Lett (2015) 0.77
MTSS1 gene regulated by miR-96 inhibits cell proliferation and metastasis in tongue squamous cellular carcinoma Tca8113 cell line. Int J Clin Exp Med (2015) 0.76
Factors affecting the yield of microRNAs from laser microdissectates of formalin-fixed tissue sections. BMC Res Notes (2012) 0.76
Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 induction. Oncotarget (2016) 0.75
Gene expression of protein-coding and non-coding RNAs related to polyembryogenesis in the parasitic wasp, Copidosoma floridanum. PLoS One (2014) 0.75
Evaluation and Adaptation of a Laboratory-Based cDNA Library Preparation Protocol for Retrospective Sequencing of Archived MicroRNAs from up to 35-Year-Old Clinical FFPE Specimens. Int J Mol Sci (2017) 0.75
Identification of microRNAs dysregulated in CD14 gene silencing RAW264.7 macrophage cells. Inflammation (2014) 0.75
RNA sequencing for global gene expression associated with muscle growth in a single male modern broiler line compared to a foundational Barred Plymouth Rock chicken line. BMC Genomics (2017) 0.75
Syndecans as Cell Surface Receptors in Cancer Biology. A Focus on their Interaction with PDZ Domain Proteins. Front Pharmacol (2016) 0.75
A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer. PLoS One (2016) 0.75
Challenging paradigms: long non-coding RNAs in breast ductal carcinoma in situ (DCIS). Front Genet (2013) 0.75
Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential. BMC Syst Biol (2015) 0.75
Noncoding RNAs in breast cancer. Brief Funct Genomics (2015) 0.75
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99
MicroRNA expression profiles classify human cancers. Nature (2005) 69.12
Prediction of mammalian microRNA targets. Cell (2003) 53.70
Combinatorial microRNA target predictions. Nat Genet (2005) 50.48
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature (2005) 48.95
A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A (2006) 40.09
miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res (2006) 39.25
Most mammalian mRNAs are conserved targets of microRNAs. Genome Res (2008) 37.16
MicroRNA gene expression deregulation in human breast cancer. Cancer Res (2005) 27.56
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol (2008) 24.27
Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature (2010) 22.04
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature (2007) 21.53
Switching from repression to activation: microRNAs can up-regulate translation. Science (2007) 17.00
The microRNA.org resource: targets and expression. Nucleic Acids Res (2007) 16.26
Requirement of bic/microRNA-155 for normal immune function. Science (2007) 16.24
Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA (2005) 14.14
miR-21-mediated tumor growth. Oncogene (2006) 9.90
Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res (2005) 9.80
Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell (2006) 8.46
microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A (2006) 8.24
Fundamentals of experimental design for cDNA microarrays. Nat Genet (2002) 7.49
Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem (2007) 7.46
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol (2007) 6.41
MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A (2008) 6.38
MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol Cell (2007) 5.67
MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res (2008) 5.54
Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer (2006) 5.47
Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res (2007) 5.25
Non-coding RNAs: regulators of disease. J Pathol (2010) 5.12
Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem (2006) 4.59
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer (2010) 4.53
Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J (1995) 4.23
Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci U S A (2009) 4.00
Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem (2009) 3.89
miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J Mol Biol (2008) 3.26
Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc Natl Acad Sci U S A (2008) 3.08
A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol (2008) 3.02
MicroRNAs: a new class of regulatory genes affecting metabolism. Cell Metab (2006) 2.84
MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology (2009) 2.57
Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab Invest (2009) 2.43
Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer (2009) 2.32
The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Ther (2006) 2.24
A bioinformatics tool for linking gene expression profiling results with public databases of microRNA target predictions. RNA (2008) 2.16
An elegant miRror: microRNAs in stem cells, developmental timing and cancer. Chromosoma (2009) 1.99
Mitochondrial Dok-4 recruits Src kinase and regulates NF-kappaB activation in endothelial cells. J Biol Chem (2005) 1.59
Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients. Int J Cancer (2008) 1.51
MicroRNA mir-346 targets the 5'-untranslated region of receptor-interacting protein 140 (RIP140) mRNA and up-regulates its protein expression. Biochem J (2009) 1.49
Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer. Breast Cancer Res Treat (2010) 1.38
Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer. Oncogene (2009) 1.37
Identification of DOK genes as lung tumor suppressors. Nat Genet (2010) 1.32
Reliability and reproducibility of gene expression measurements using amplified RNA from laser-microdissected primary breast tissue with oligonucleotide arrays. J Mol Diagn (2005) 1.30
Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile. Br J Cancer (2010) 1.29
Chromobox protein homologue 7 protein, with decreased expression in human carcinomas, positively regulates E-cadherin expression by interacting with the histone deacetylase 2 protein. Cancer Res (2009) 1.25
Early dysregulation of cell adhesion and extracellular matrix pathways in breast cancer progression. Am J Pathol (2009) 1.07
[Differential expression profiles of microRNAs between breast cancer cells and mammary epithelial cells]. Ai Zheng (2009) 0.91
Myristoyl-CoA:protein N-myristoyltransferase: a novel molecular approach for cancer therapy (Review). Int J Mol Med (2002) 0.84
Memo is homologous to nonheme iron dioxygenases and binds an ErbB2-derived phosphopeptide in its vestigial active site. J Biol Chem (2007) 0.83
Pleckstrin homology and phosphotyrosine-binding domain-dependent membrane association and tyrosine phosphorylation of Dok-4, an inhibitory adapter molecule expressed in epithelial cells. J Biol Chem (2004) 0.82
Implementing syndromic surveillance: a practical guide informed by the early experience. J Am Med Inform Assoc (2003) 6.75
Disentangling the roles of disability and morbidity in survival to exceptional old age. Arch Intern Med (2008) 4.77
Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med (2007) 4.63
Cluster analysis of gene expression dynamics. Proc Natl Acad Sci U S A (2002) 3.83
BET bromodomain inhibition as a novel strategy for reactivation of HIV-1. J Leukoc Biol (2012) 2.80
Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster. Blood (2009) 2.50
Fetal hemoglobin in sickle cell anemia. Blood (2011) 2.44
MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci U S A (2009) 2.37
Imputation of missing genotypes: an empirical evaluation of IMPUTE. BMC Genet (2008) 2.34
Notch signaling controls the balance of ciliated and secretory cell fates in developing airways. Development (2009) 2.33
Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span. J Gerontol A Biol Sci Med Sci (2012) 2.30
Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res (2009) 2.23
Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression. Genome Biol (2007) 2.20
Fetal hemoglobin in sickle cell anemia: a glass half full? Blood (2013) 2.19
A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study. BMC Med Genet (2007) 1.81
Health and function of participants in the Long Life Family Study: A comparison with other cohorts. Aging (Albany NY) (2011) 1.74
A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment. Am J Respir Crit Care Med (2013) 1.73
Genetic modifiers of sickle cell disease. Am J Hematol (2012) 1.66
Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign. Br J Haematol (2013) 1.63
Fetal hemoglobin in sickle cell anemia: genetic studies of the Arab-Indian haplotype. Blood Cells Mol Dis (2013) 1.54
Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway. Br J Haematol (2006) 1.51
Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients. Int J Cancer (2008) 1.51
CYP2D6 inhibition and breast cancer recurrence in a population-based study in Denmark. J Natl Cancer Inst (2011) 1.47
A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression. Blood (2011) 1.47
Similarities and differences between smoking-related gene expression in nasal and bronchial epithelium. Physiol Genomics (2009) 1.42
A prediction model for lung cancer diagnosis that integrates genomic and clinical features. Cancer Prev Res (Phila) (2008) 1.41
Gamma-secretase activation of notch signaling regulates the balance of proximal and distal fates in progenitor cells of the developing lung. J Biol Chem (2008) 1.40
Retraction. Science (2011) 1.32
Reliability and reproducibility of gene expression measurements using amplified RNA from laser-microdissected primary breast tissue with oligonucleotide arrays. J Mol Diagn (2005) 1.30
Fetal hemoglobin in sickle cell anemia: molecular characterization of the unusually high fetal hemoglobin phenotype in African Americans. Am J Hematol (2011) 1.26
Risk of breast cancer in women exposed to diethylstilbestrol in utero: prelimiinary results (United States). Cancer Causes Control (2002) 1.20
Bayesian methods for multivariate modeling of pleiotropic SNP associations and genetic risk prediction. Front Genet (2012) 1.19
CDKN1C/p57kip2 is a candidate tumor suppressor gene in human breast cancer. BMC Cancer (2008) 1.17
The SPARC-related factor SMOC-2 promotes growth factor-induced cyclin D1 expression and DNA synthesis via integrin-linked kinase. Mol Biol Cell (2007) 1.16
Bayesian approaches to reverse engineer cellular systems: a simulation study on nonlinear Gaussian networks. BMC Bioinformatics (2007) 1.14
Clustering by genetic ancestry using genome-wide SNP data. BMC Genet (2010) 1.12
Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans. Blood (2012) 1.12
The transforming growth factor-beta pathway is a common target of drugs that prevent experimental diabetic retinopathy. Diabetes (2009) 1.11
Transcriptional analysis of fracture healing and the induction of embryonic stem cell-related genes. PLoS One (2009) 1.11
Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis. Blood (2005) 1.11
Early dysregulation of cell adhesion and extracellular matrix pathways in breast cancer progression. Am J Pathol (2009) 1.07
Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen. Acta Oncol (2010) 1.07
Concordance of metabolic enzyme genotypes assayed from paraffin-embedded, formalin-fixed breast tumors and normal lymphatic tissue. Clin Epidemiol (2010) 1.06
Evidence and practice regarding the role for CYP2D6 inhibition in decisions about tamoxifen therapy. J Clin Oncol (2010) 1.06
Gene expression profiles of estrogen receptor-positive and estrogen receptor-negative breast cancers are detectable in histologically normal breast epithelium. Clin Cancer Res (2010) 1.05
Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomas. Am J Pathol (2002) 1.05
A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. PLoS One (2012) 1.04
Polysomy 17 and HER-2 amplification: true, true, and unrelated. J Clin Oncol (2008) 1.04
A Shh/miR-206/BDNF cascade coordinates innervation and formation of airway smooth muscle. J Neurosci (2011) 1.03
Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence. J Clin Oncol (2004) 1.03
Leg ulcers in sickle cell disease. Am J Hematol (2010) 1.01
Association between wind speed and the occurrence of sickle cell acute painful episodes: results of a case-crossover study. Br J Haematol (2008) 1.00
Factors affecting automated syndromic surveillance. Artif Intell Med (2005) 0.99
Use of tamoxifen with postsurgical irradiation may improve survival in estrogen and progesterone receptor-positive male breast cancer. Clin Breast Cancer (2011) 0.99
Ancestry of African Americans with sickle cell disease. Blood Cells Mol Dis (2011) 0.96
Genome-wide association study of personality traits in the long life family study. Front Genet (2013) 0.96
Prediction of fetal hemoglobin in sickle cell anemia using an ensemble of genetic risk prediction models. Circ Cardiovasc Genet (2014) 0.95
Systemic inactivation of Hs6st1 in mice is associated with late postnatal mortality without major defects in organogenesis. Genesis (2008) 0.95
Allele imbalance, or loss of heterozygosity, in normal breast epithelium of sporadic breast cancer cases and BRCA1 gene mutation carriers is increased compared with reduction mammoplasty tissues. J Clin Oncol (2005) 0.95
Hypoxic response contributes to altered gene expression and precapillary pulmonary hypertension in patients with sickle cell disease. Circulation (2014) 0.92
Conditional clustering of temporal expression profiles. BMC Bioinformatics (2008) 0.92
Meta‐analysis of genetic variants associated with human exceptional longevity. Aging (Albany NY) (2013) 0.92
Human longevity and common variations in the LMNA gene: a meta-analysis. Aging Cell (2012) 0.90
Genetic determinants of haemolysis in sickle cell anaemia. Br J Haematol (2013) 0.89
Modification of tamoxifen response: what have we learned? J Clin Oncol (2008) 0.89
Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis. Am J Epidemiol (2014) 0.89
Personality traits of centenarians' offspring. J Am Geriatr Soc (2009) 0.88
Abnormal anal cytology in HIV-infected women. Am J Obstet Gynecol (2010) 0.88
Single nucleotide polymorphisms associated with sporadic brain arteriovenous malformations: where do we stand? Brain (2012) 0.87
Personality factors in the Long Life Family Study. J Gerontol B Psychol Sci Soc Sci (2012) 0.87
Premature expression of a muscle fibrosis axis in chronic HIV infection. Skelet Muscle (2012) 0.86
Characterization of the mid-foregut transcriptome identifies genes regulated during lung bud induction. Gene Expr Patterns (2007) 0.86
Evidence for cross-regulated cytokine response in human peripheral blood mononuclear cells exposed to whole gonococcal bacteria in vitro. Microb Pathog (2006) 0.86
Identification of serum biomarkers for aging and anabolic response. Immun Ageing (2011) 0.86
Evolution and challenges in the design of computational systems for triage assistance. J Biomed Inform (2008) 0.85
Genetic polymorphism of APOB is associated with diabetes mellitus in sickle cell disease. Hum Genet (2015) 0.85
Differential gene expression in pulmonary artery endothelial cells exposed to sickle cell plasma. Physiol Genomics (2005) 0.85
Severe sickle cell anemia is associated with increased plasma levels of TNF-R1 and VCAM-1. Am J Hematol (2011) 0.85
Extended maternal age at birth of last child and women's longevity in the Long Life Family Study. Menopause (2015) 0.85
Building chromosome-wide LD maps. Bioinformatics (2006) 0.84
Loss of heterozygosity in serial plasma DNA samples during follow-up of women with breast cancer. Int J Cancer (2003) 0.84
Anaplastic thyroid cancer: outcome and the mutation/expression profiles of potential targets. Pathol Oncol Res (2015) 0.82
PleioGRiP: genetic risk prediction with pleiotropy. Bioinformatics (2013) 0.82
Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss. J Clin Endocrinol Metab (2007) 0.82
Prediction models that include genetic data. Circ Cardiovasc Genet (2010) 0.82
Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors. Cancer Epidemiol Biomarkers Prev (2011) 0.81
Age validation in the long life family study through a linkage to early-life census records. J Gerontol B Psychol Sci Soc Sci (2013) 0.81
Grainyhead-like 2 (GRHL2) distribution reveals novel pathophysiological differences between human idiopathic pulmonary fibrosis and mouse models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2013) 0.81
Relationship between poor physical function, inflammatory markers, and comorbidities in HIV-infected women on antiretroviral therapy. J Womens Health (Larchmt) (2013) 0.80
A new approach for the study of lung smooth muscle phenotypes and its application in a murine model of allergic airway inflammation. PLoS One (2013) 0.80
In utero exposure to diethylstilbestrol (DES) does not increase genomic instability in normal or neoplastic breast epithelium. Cancer (2006) 0.80
Genetic studies of fetal hemoglobin in the Arab-Indian haplotype sickle cell-β(0) thalassemia. Am J Hematol (2013) 0.75
The genetics of hemoglobin A2 regulation in sickle cell anemia. Am J Hematol (2014) 0.75
Telomere length is longer in women with late maternal age. Menopause (2016) 0.75